0
Facebook
Volume 92 Issue 19 | p. 29 | Concentrates
Issue Date: May 12, 2014

Protein Target Of Clot-Preventing Drugs Seen For The First Time

P2Y12 receptor’s X-ray structure reveals protein pockets that may prove useful in drug design
Department: Science & Technology
News Channels: Biological SCENE, Analytical SCENE
Keywords: crystallography, drug development, medicinal chemistry, structural biology, anticoagulant
[+]Enlarge
This view from outside the cell compares P2Y12 binding to an inactivator (purple ribbon, yellow stick) and an activator (green ribbon, orange and blue stick).
Credit: Courtesy of Silvia Paoletta
09219-scicon-proteincxd
 
This view from outside the cell compares P2Y12 binding to an inactivator (purple ribbon, yellow stick) and an activator (green ribbon, orange and blue stick).
Credit: Courtesy of Silvia Paoletta

The blockbuster blood-clot-preventing medication Plavix (clopidogrel) was discovered before researchers knew much about its biochemical target, which is a protein receptor called P2Y12. Today, however, they can at last see P2Y12’s structure, which could lead to next-generation drugs. Qiang Zhao of Shanghai Institute of Materia Medica teamed with Raymond C. Stevens of Scripps Research Institute California, Kenneth A. Jacobson of NIH, and their colleagues to solve P2Y12’s crystal structure (Nature 2014, DOI: 10.1038/nature13083 and 10.1038/nature13288). The researchers knew that P2Y12 is a G protein-coupled receptor, a protein that snakes across the cell membrane seven times. But they didn’t know that the conformation of its extracellular protein loops differs dramatically depending on whether P2Y12 is binding to an activator or an inactivator. What’s more, P2Y12 has two subpockets in its binding site, and none of the drugs that target the receptor takes advantage of both. Jacobson notes that chemists are seeking next-generation clot fighters that carry a lower risk of bleeding than established drugs. “Without these structures, we were working in the dark,” he says.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society